Surgical adjuvant therapy for malignant melanoma.
D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D001500:BCG Vaccine / Q000009:adverse effects / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D007167:Immunotherapy; D008297:Male; D008545:Melanoma / Q000401:mortality / Q000601:surgery / Q000628:therapy*; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local; D011425:Propionibacterium acnes / Q000276:immunology; D011549:Pseudomonas / Q000276:immunology; D012878:Skin Neoplasms / Q000601:surgery / Q000628:therapy*; D013997:Time Factors
D000970:Antineoplastic Agents; D001500:BCG Vaccine